Free Trial

Ascend Wellness (OTCMKTS:AAWH) Rating Lowered to "Strong Sell" at Zacks Research

Ascend Wellness logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Zacks Research downgraded Ascend Wellness (OTCMKTS:AAWH) from a "hold" to a Strong Sell in a report issued Thursday.
  • The company last reported quarterly EPS of ($0.16) versus consensus ($0.12), missing estimates while revenue of $120.55M slightly beat expectations; analysts now forecast about -0.4 EPS for the current year and the business shows deeply negative profitability (ROE -1,099.51%, net margin -23.61%).
  • Shares trade around $0.44 with a 12‑month range of $0.26–$1.20, a market cap of roughly $90.8M, a negative P/E of -0.77 and a high debt-to-equity ratio of 133.34, highlighting leverage and weak valuation.
  • Five stocks we like better than Ascend Wellness.

Ascend Wellness (OTCMKTS:AAWH - Get Free Report) was downgraded by research analysts at Zacks Research from a "hold" rating to a "strong sell" rating in a research report issued on Thursday,Zacks.com reports.

Ascend Wellness Price Performance

Shares of OTCMKTS:AAWH opened at $0.44 on Thursday. Ascend Wellness has a twelve month low of $0.26 and a twelve month high of $1.20. The company's 50 day moving average is $0.55 and its 200 day moving average is $0.65. The company has a current ratio of 1.92, a quick ratio of 1.14 and a debt-to-equity ratio of 133.34. The company has a market cap of $90.77 million, a PE ratio of -0.77 and a beta of 1.12.

Ascend Wellness (OTCMKTS:AAWH - Get Free Report) last posted its quarterly earnings results on Thursday, March 12th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.12) by ($0.04). The business had revenue of $120.55 million for the quarter, compared to analysts' expectations of $120.00 million. Ascend Wellness had a negative return on equity of 1,099.51% and a negative net margin of 23.61%. On average, sell-side analysts forecast that Ascend Wellness will post -0.4 EPS for the current year.

About Ascend Wellness

(Get Free Report)

Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands. It also owns, operates, and manages cannabis cultivation facilities and dispensaries. The company sells its products through company-owned retail stores and third-party licensed retail cannabis stores.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Ascend Wellness Right Now?

Before you consider Ascend Wellness, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ascend Wellness wasn't on the list.

While Ascend Wellness currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines